Literature DB >> 24485488

Evidence for alterations in stimulatory G proteins and oxytocin levels in children with autism.

Jill D Jacobson1, Kathryn A Ellerbeck2, Kelsie A Kelly2, Kandace K Fleming3, T Rene Jamison2, Charles W Coffey2, Catherine M Smith2, R Matthew Reese2, Scott A Sands4.   

Abstract

The neurotransmitter oxytocin plays an important role in social affiliation. Low oxytocin levels and defects in the oxytocin receptor have been reported in childhood autism. However, little is known about oxytocin's post-receptor signaling pathways in autism. Oxytocin signals via stimulatory and inhibitory G proteins. c-fos mRNA expression has been used as a marker of OT signaling as well as of G protein signaling. Herein, we hypothesized that oxytocin and its signaling pathways would be altered in children with autism. We measured plasma oxytocin levels by ELISA, G-protein and c-fos mRNA by PCR, and G proteins by immunoblot in cultured peripheral blood mononuclear cells (PBMCs) in children with autism and in age-matched controls. Males with autism displayed elevated oxytocin levels compared to controls (p<0.05). Children with autism displayed significantly higher mRNA for stimulatory G proteins compared to controls (p<0.05). Oxytocin levels correlated strongly positively with c-fos mRNA levels, but only in control participants (p<0.01). Oxytocin, G-protein, and c-fos mRNA levels correlated inversely with measures of social and emotional behaviors, but only in control participants. These data suggest that children with autism may exhibit a dysregulation in oxytocin and/or its signaling pathways.
Copyright © 2013. Published by Elsevier Ltd.

Entities:  

Keywords:  ADI-R; ADOS; Autism; Autism in early childhood; G protein; Oxytocin; Signaling

Mesh:

Substances:

Year:  2013        PMID: 24485488      PMCID: PMC4259400          DOI: 10.1016/j.psyneuen.2013.11.014

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  52 in total

1.  Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders.

Authors:  Eric Hollander; Sherie Novotny; Margaret Hanratty; Rona Yaffe; Concetta M DeCaria; Bonnie R Aronowitz; Serge Mosovich
Journal:  Neuropsychopharmacology       Date:  2003-01       Impact factor: 7.853

2.  Examining autism spectrum disorders by biomarkers: example from the oxytocin and serotonin systems.

Authors:  Elizabeth Hammock; Jeremy Veenstra-VanderWeele; Zhongyu Yan; Travis M Kerr; Marianna Morris; George M Anderson; C Sue Carter; Edwin H Cook; Suma Jacob
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2012-05-26       Impact factor: 8.829

3.  Altered oxytocin and vasopressin levels in autistic children in Central Saudi Arabia.

Authors:  Laila Y Al-Ayadhi
Journal:  Neurosciences (Riyadh)       Date:  2005-01       Impact factor: 0.906

4.  Depressed concentrations of oxytocin and cortisol in children with recurrent abdominal pain of non-organic origin.

Authors:  G Alfvén; B de la Torre; K Uvnäs-Moberg
Journal:  Acta Paediatr       Date:  1994-10       Impact factor: 2.299

5.  The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism.

Authors:  C Lord; S Risi; L Lambrecht; E H Cook; B L Leventhal; P C DiLavore; A Pickles; M Rutter
Journal:  J Autism Dev Disord       Date:  2000-06

Review 6.  Modulating social behavior with oxytocin: how does it work? What does it mean?

Authors:  Patricia S Churchland; Piotr Winkielman
Journal:  Horm Behav       Date:  2011-12-14       Impact factor: 3.587

7.  Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008.

Authors: 
Journal:  MMWR Surveill Summ       Date:  2012-03-30

8.  Dual modulation of inward rectifier potassium currents in olfactory neuronal cells by promiscuous G protein coupling of the oxytocin receptor.

Authors:  Marta Gravati; Marta Busnelli; Elisabetta Bulgheroni; Alessandra Reversi; Paolo Spaiardi; Marco Parenti; Mauro Toselli; Bice Chini
Journal:  J Neurochem       Date:  2010-06-14       Impact factor: 5.372

9.  Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders.

Authors:  C Lord; M Rutter; A Le Couteur
Journal:  J Autism Dev Disord       Date:  1994-10

Review 10.  Impact of prosocial neuropeptides on human brain function.

Authors:  Andreas Meyer-Lindenberg
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

View more
  16 in total

1.  Genetic modulation of oxytocin's effects in social functioning.

Authors:  Huiping Huang; Francesco Papaleo
Journal:  Ann Transl Med       Date:  2015-12

2.  Functional Genomic Analyses Identify Pathways Dysregulated in Animal Model of Autism.

Authors:  Ji-Yun Huang; Yun Tian; Hui-Juan Wang; Hong Shen; Huan Wang; Sen Long; Mei-Hua Liao; Zhi-Rong Liu; Ze-Ming Wang; Dan Li; Rong-Rong Tao; Tian-Tian Cui; Shigeki Moriguchi; Kohji Fukunaga; Feng Han; Ying-Mei Lu
Journal:  CNS Neurosci Ther       Date:  2016-06-20       Impact factor: 5.243

Review 3.  A Precision Medicine Approach to Oxytocin Trials.

Authors:  Elissar Andari; Rene Hurlemann; Larry J Young
Journal:  Curr Top Behav Neurosci       Date:  2018

4.  Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism.

Authors:  Olga Peñagarikano; María T Lázaro; Xiao-Hong Lu; Aaron Gordon; Hongmei Dong; Hoa A Lam; Elior Peles; Nigel T Maidment; Niall P Murphy; X William Yang; Peyman Golshani; Daniel H Geschwind
Journal:  Sci Transl Med       Date:  2015-01-21       Impact factor: 17.956

5.  Plasma Oxytocin and Arginine-Vasopressin Levels in Children with Autism Spectrum Disorder in China: Associations with Symptoms.

Authors:  Hong-Feng Zhang; Yu-Chuan Dai; Jing Wu; Mei-Xiang Jia; Ji-Shui Zhang; Xiao-Jing Shou; Song-Ping Han; Rong Zhang; Ji-Sheng Han
Journal:  Neurosci Bull       Date:  2016-06-24       Impact factor: 5.203

Review 6.  New Therapeutic Options for Autism Spectrum Disorder: Experimental Evidences.

Authors:  Olga Peñagarikano
Journal:  Exp Neurobiol       Date:  2015-12-16       Impact factor: 3.261

7.  Cross-disorder comparative analysis of comorbid conditions reveals novel autism candidate genes.

Authors:  Leticia Diaz-Beltran; Francisco J Esteban; Maya Varma; Alp Ortuzk; Maude David; Dennis P Wall
Journal:  BMC Genomics       Date:  2017-04-20       Impact factor: 3.969

8.  Serum Oxytocin Levels and an Oxytocin Receptor Gene Polymorphism (rs2254298) Indicate Social Deficits in Children and Adolescents with Autism Spectrum Disorders.

Authors:  Shuhan Yang; Xiaopeng Dong; Xuan Guo; Yu Han; Hanbing Song; Lei Gao; Wei Dai; Yuanyuan Su; Xin Zhang
Journal:  Front Neurosci       Date:  2017-04-21       Impact factor: 4.677

Review 9.  The Potential of Nasal Oxytocin Administration for Remediation of Autism Spectrum Disorders.

Authors:  Yuko Okamoto; Makoto Ishitobi; Yuji Wada; Hirotaka Kosaka
Journal:  CNS Neurol Disord Drug Targets       Date:  2016       Impact factor: 4.388

Review 10.  A common molecular signature in ASD gene expression: following Root 66 to autism.

Authors:  L Diaz-Beltran; F J Esteban; D P Wall
Journal:  Transl Psychiatry       Date:  2016-01-05       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.